Dataset Information

Structure cristalline de type alluaudite K0.4Na3.6Co(MoO4)3.

ABSTRACT: A new triple molybdate, potassium sodium cobalt tris-(molybdate), K0.4Na3.6Co(MoO4)3, was synthesized using solid-state reactions. The Co(2+) and one Na(+) cation are located at the same general site, each with occupancy 0.5. Another site (site symmetry 2) is occupied by Na(+) and K(+) cations, with occupancies of 0.597?(7) and 0.402?(6), respectively. The other two Na(+) cations and one of the two Mo atoms lie on special positions (site symmetries -1, 2 and 2, respectively). The structure is characterized by M 2O10 (M = Co/Na) dimers, which are linked by MoO4 tetra-hedra, forming infinite layers. The latter are connected firstly by insertion of one type of MoO4 tetra-hedra and secondly by sharing corners with the other type of MoO4 tetra-hedra. This results in an open three-dimensional framework with the cavities occupied by the Na(+) and K(+) cations. The structure is isotypic with Na3In2As3O12 and Na3In2P3O12. A comparison is made with structures such as K2Co2(MoO4)3 and ?-NaFe2(MoO4)3 and their differences are discussed.

SUBMITTER: Nasri R

PROVIDER: S-EPMC4331865 | biostudies-other | 2015 Jan

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Structure cristalline de type alluaudite K0.4Na3.6Co(MoO4)3.

Nasri Rawia R Fakhar Bourguiba Noura N Zid Mohamed Faouzi MF

Acta crystallographica. Section E, Crystallographic communications 20150101 Pt 1

A new triple molybdate, potassium sodium cobalt tris-(molybdate), K0.4Na3.6Co(MoO4)3, was synthesized using solid-state reactions. The Co(2+) and one Na(+) cation are located at the same general site, each with occupancy 0.5. Another site (site symmetry 2) is occupied by Na(+) and K(+) cations, with occupancies of 0.597 (7) and 0.402 (6), respectively. The other two Na(+) cations and one of the two Mo atoms lie on special positions (site symmetries -1, 2 and 2, respectively). The structure is ch ...[more]

PMID: 25705436

Similar Datasets

Project description:Background: Despite significant improvements in short-term kidney transplant survival, comparable increases in 5 and 10-year outcomes have not been achieved. Chronic allograft nephropathy (CAN) is a major cause of late graft loss. Toxic nephropathy and inadequate long-term immunosuppression are possible factors. We performed a randomized prospective trial comparing calcineurin inhibitor (CNI)-free to CNI-based immunosuppression to determine the impact on renal function, structure, and gene expression. Methods: Sixty-one kidney recipients received mycophenolate mofetil (MMF), and prednisone (P). Randomized patients received concentration-controlled sirolimus or cyclosporine. Two years post-transplant 55 patients underwent renal function studies, 48 (87%) underwent transplant biopsies; all classified by Banff scoring and 41 by DNA microarrays. Findings: Comparing sirolimus/MMF/P to cyclosporine/MMF/P at two years, there was a significantly lower serum creatinine (1.35 vs. 1.81 mg/dl; p=0.008), significantly higher Cockroft-Gault glomerular filtration rate (GFR) (80.4 vs. 63.4 cc/min; p=0.008), iothalamate GFR (60.6 vs. 49.2 cc/min; p= 0.018), and Banff 0 (normal) biopsies (66.6 vs. 20.8%; p=0.013). Regression analysis of calculated GFR’s from 1 to 36 months yielded a positive slope for sirolimus of 3.36 ml/min/year, and a negative slope for cyclosporine of –1.58 ml/min/year (p=0.008). Gene expression profiles of kidney biopsies with higher Banff CAN scores confirmed significant up regulation of genes responsible for immune/inflammation and fibrosis/tissue remodeling. Interpretation: At two years the sirolimus-treated patients have better renal transplant function, a diminished prevalence of CAN, and down regulated expression of genes responsible for the progression of CAN. All may provide for an alternative natural history with improved graft survival. Keywords = Cyclosporine Keywords = Sirolimus Keywords = Transplantation Keywords = DNA microarrays Keywords = calcineurin inhibitors Keywords: parallel sample. This dataset is part of the TransQST collection.

Dataset Information

Structure cristalline de type alluaudite K0.4Na3.6Co(MoO4)3.

Publications

Structure cristalline de type alluaudite K0.4Na3.6Co(MoO4)3.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure